Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma
Titel:
Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma
Auteur:
Sonpavde, Guru P. Sternberg, Cora N. Loriot, Yohann Marabelle, Aurelien Lee, Jae Lyun Fléchon, Aude Roubaud, Guilhem Pouessel, Damien Zagonel, Vittorina Calabro, Fabio Banna, Giuseppe L. Shin, Sang Joon Vera-Badillo, Francisco E. Powles, Thomas Hellmis, Eva Miranda, Paulo A.P. Lima, Ana Rita Emeribe, Ugochi Oh, Sun Min Hotte, Sebastien J.